Pfizer enters medical cannabis market with new acquisition
Pharma titan Pfizer is to acquire Arena Pharmaceuticals which has a pipeline in cannabinoid therapeutics.Â
Read moreStephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Pharma titan Pfizer is to acquire Arena Pharmaceuticals which has a pipeline in cannabinoid therapeutics.Â
Read more2021 has been a good year for the cannabis industry, says the new Brightfield Group report.
Read moreKanabo has moved one step closer to patent approval and called for the UK to set up CBD inhalation regulation.
Read moreThe products will allow patients to administer metered doses of their medicines.
Read moreMalta has officially passed a bill to legalise the adult use of cannabis.
Read moreThe UK’s Foods Standards Agency has provided an update on its current status in relation to CBD Novel Foods applications.
Read moreChristopher Tasker of Global Cannabinoid Solutions (GCS) discusses the rise of delta-8-THC.
Read moreMore than 50 Maltese NGOs and academics have petitioned the Government to amend its cannabis bill.
Read moreCBD brand Love Hemp has announced its full financial results for the year.
Read moreA new bipartisan bill has been introduced by Members of the US House of Representatives.
Read more© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.